Differentiation between benign and malignant breast lesions detected by bilateral dynamic contrast‐enhanced MRI: A sensitivity and specificity study
暂无分享,去创建一个
Hiroyuki Abe | Xiaobing Fan | G. Newstead | S. Jansen | H. Abe | G. Karczmar | R. Schmidt | Xiaobing Fan | Sanaz A. Jansen | Gregory S. Karczmar | Robert A. Schmidt | Gillian M. Newstead
[1] Claudia Weidensteiner,et al. Quantitative dynamic contrast‐enhanced MRI in tumor‐bearing rats and mice with inversion recovery TrueFISP and two contrast agents at 4.7 T , 2006, Journal of magnetic resonance imaging : JMRI.
[2] C. Metz,et al. Maximum likelihood estimation of receiver operating characteristic (ROC) curves from continuously-distributed data. , 1998, Statistics in medicine.
[3] Mariko Goto,et al. Diagnosis of breast tumors by contrast‐enhanced MR imaging: Comparison between the diagnostic performance of dynamic enhancement patterns and morphologic features , 2007, Journal of magnetic resonance imaging : JMRI.
[4] Cheryl Jorcyk,et al. The C3(1)/SV40 T-antigen transgenic mouse model of mammary cancer: ductal epithelial cell targeting with multistage progression to carcinoma , 2000, Oncogene.
[5] Chiara Zuiani,et al. Contrast-enhanced breast MRI in patients with suspicious microcalcifications on mammography: results of a multicenter trial. , 2006, AJR. American journal of roentgenology.
[6] R. Schmidt,et al. Pure ductal carcinoma in situ: kinetic and morphologic MR characteristics compared with mammographic appearance and nuclear grade. , 2007, Radiology.
[7] John Gosbee,et al. ACR guidance document for safe MR practices: 2007. , 2007, AJR. American journal of roentgenology.
[8] S. Harms. The Use of Breast Magnetic Resonance Imaging in Ductal Carcinoma in Situ , 2005, The breast journal.
[9] Wei Huang,et al. Enhancing nonmass lesions in the breast: evaluation with proton (1H) MR spectroscopy. , 2007, Radiology.
[10] A. Goode,et al. The magnetization transfer characteristics of human breast tissues: an in vitro NMR study. , 1999, Physics in medicine and biology.
[11] N. Hylton,et al. Diagnostic architectural and dynamic features at breast MR imaging: multicenter study. , 2006, Radiology.
[12] Michael Brady,et al. Extracting and visualizing physiological parameters using dynamic contrast-enhanced magnetic resonance imaging of the breast , 2005, Medical Image Anal..
[13] J. Hogg. Magnetic resonance imaging. , 1994, Journal of the Royal Naval Medical Service.
[14] C. Claussen,et al. Influence of age and menstrual cycle on mammography and MR imaging of the breast , 1997, Der Radiologe.
[15] G. Newstead,et al. Detection of in situ mammary cancer in a transgenic mouse model: in vitro and in vivo MRI studies demonstrate histopathologic correlation , 2008, Physics in medicine and biology.
[16] B. Porter,et al. Contrast-enhanced breast magnetic resonance imaging: the surgical perspective. , 2007, American journal of surgery.
[17] C. Kuhl. Concepts for differential diagnosis in breast MR imaging. , 2006, Magnetic resonance imaging clinics of North America.
[18] Erica Markiewicz,et al. High spectral and spatial resolution MRI of age‐related changes in murine prostate , 2008, Magnetic resonance in medicine.
[19] Fiona J Gilbert,et al. Reading protocol for dynamic contrast-enhanced MR images of the breast: sensitivity and specificity analysis. , 2005, Radiology.
[20] C. Catalano,et al. Breast lesion detection and characterization at contrast-enhanced MR mammography: gadobenate dimeglumine versus gadopentetate dimeglumine. , 2005, Radiology.
[21] M. Yaffe,et al. American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography , 2007 .
[22] P. Parizel,et al. Comparison of MRI features of different grades of DCIS and invasive carcinoma of the breast. , 2006, JBR-BTR : organe de la Societe royale belge de radiologie (SRBR) = orgaan van de Koninklijke Belgische Vereniging voor Radiologie.
[23] W. Kaiser,et al. High grade and non-high grade ductal carcinoma in situ on dynamic MR mammography: characteristic findings for signal increase and morphological pattern of enhancement. , 2003, The British journal of radiology.
[24] G Lutterbey,et al. Healthy premenopausal breast parenchyma in dynamic contrast-enhanced MR imaging of the breast: normal contrast medium enhancement and cyclical-phase dependency. , 1997, Radiology.
[25] D. D. Billheimer,et al. Repeatability of a reference region model for analysis of murine DCE‐MRI data at 7T , 2006, Journal of magnetic resonance imaging : JMRI.
[26] Wendy B DeMartini,et al. Breast MR imaging: computer-aided evaluation program for discriminating benign from malignant lesions. , 2007, Radiology.
[27] L. Tabár,et al. Mammography and breast cancer: the new era , 2003, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[28] L. Liberman. Breast MR imaging in assessing extent of disease. , 2006, Magnetic resonance imaging clinics of North America.
[29] C. Kuhl,et al. Präoperatives Staging mit der Mamma-MRT: Pro und Kontra , 2008, Der Radiologe.
[30] A R Padhani,et al. Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS) , 2005, The Lancet.
[31] Edna Furman-Haran,et al. Parametric analysis of breast MRI. , 2002, Journal of computer assisted tomography.
[32] Peter Bult,et al. The value of magnetic resonance imaging in diagnosis and size assessment of in situ and small invasive breast carcinoma. , 2006, American journal of surgery.
[33] F. Kelcz,et al. Magnetic resonance imaging of breast cancer angiogenesis: a review. , 2002, Journal of experimental & clinical cancer research : CR.
[34] O Lucidarme,et al. Clustered breast microcalcifications: evaluation by dynamic contrast-enhanced subtraction MRI. , 1996, Journal of computer assisted tomography.
[35] C. Quinn,et al. Angiogenesis, thrombospondin, and ductal carcinoma in situ of the breast , 2002, Journal of clinical pathology.
[36] G. Newstead. MR imaging in the management of patients with breast cancer. , 2006, Seminars in ultrasound, CT, and MR.
[37] F. Kelcz,et al. Improvement in breast lesion characterization with dynamic contrast‐enhanced MRI using pharmacokinetic modeling and bookend T1 measurements , 2004, Magnetic resonance in medicine.
[38] Andreas Makris,et al. Early breast cancer , 2009, The Lancet.
[39] C. Kuhl,et al. Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions? , 1999, Radiology.
[40] Tibor Tot,et al. Invasive breast cancer: correlation of dynamic MR features with prognostic factors , 2003, European Radiology.
[41] Daniel F Chen,et al. Biologic significance of false-positive magnetic resonance imaging enhancement in the setting of ductal carcinoma in situ. , 2006, American journal of surgery.
[42] G. Newstead,et al. Diagnosis of suspicious breast lesions using an empirical mathematical model for dynamic contrast-enhanced MRI. , 2007, Magnetic resonance imaging.
[43] M. Giger,et al. Automatic identification and classification of characteristic kinetic curves of breast lesions on DCE-MRI. , 2006, Medical physics.
[44] U. Fischer,et al. International investigation of breast MRI: results of a multicentre study (11 sites) concerning diagnostic parameters for contrast-enhanced MRI based on 519 histopathologically correlated lesions , 2001, European Radiology.
[45] R. Elledge,et al. Premalignant and In Situ Breast Disease: Biology and Clinical Implications , 2005, Annals of Internal Medicine.
[46] Michael Brady,et al. Analysis of dynamic MR breast images using a model of contrast enhancement , 1997, Medical Image Anal..
[47] Stefan Vogt,et al. DNA-TiO2 nanoconjugates labeled with magnetic resonance contrast agents. , 2007, Journal of the American Chemical Society.
[48] David Tritchler,et al. Heritability of mammographic density, a risk factor for breast cancer. , 2002, The New England journal of medicine.
[49] Anthony J. Guidi,et al. Microvessel density and distribution in ductal carcinoma in situ of the breast. , 1994, Journal of the National Cancer Institute.
[50] S. Heywang-Köbrunner,et al. Contrast-enhanced MR imaging of the breast: comparison of two different doses of gadopentetate dimeglumine. , 1994, Radiology.
[51] Simone Schrading,et al. MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study , 2007, The Lancet.
[52] B. Szabó,et al. Dynamic MR imaging of the breast: Analysis of kinetic and morphologic diagnostic criteria , 2003, Acta radiologica.
[53] S. Jansen. Detection and Evaluation of Early Breast Cancer via Magnetic Resonance Imaging: Studies of Mouse Models and Clinical Implementation , 2008 .
[54] Hans H Schild,et al. Dynamic bilateral contrast-enhanced MR imaging of the breast: trade-off between spatial and temporal resolution. , 2005, Radiology.
[55] M. Oudkerk,et al. Gadobenate dimeglumine-enhanced MRI of the breast: analysis of dose response and comparison with gadopentetate dimeglumine. , 2003, AJR. American journal of roentgenology.
[56] Bircan Erbas,et al. The natural history of ductal carcinoma in situ of the breast: a review , 2006, Breast Cancer Research and Treatment.
[57] Elizabeth A Morris,et al. Determination of the Presence and Extent of Pure Ductal Carcinoma in Situ by Mammography and Magnetic Resonance Imaging , 2005, The breast journal.
[58] Daniel F Chen,et al. Magnetic resonance imaging captures the biology of ductal carcinoma in situ. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[59] E. Halpern,et al. Hormone replacement therapy in postmenopausal women: breast tissue perfusion determined with MR imaging--initial observations. , 2005, Radiology.
[60] Xiaobing Fan,et al. Comparison and evaluation of mouse cardiac MRI acquired with open birdcage, single loop surface and volume birdcage coils , 2006, Physics in medicine and biology.
[61] Ellen Warner,et al. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination , 2004, JAMA.
[62] Frederick Kelcz,et al. Application of a quantitative model to differentiate benign from malignant breast lesions detected by dynamic, gadolinium‐enhanced MRI , 1996, Journal of magnetic resonance imaging : JMRI.
[63] R. Warren,et al. Characterization of pure high-grade DCIS on magnetic resonance imaging using the evolving breast MR lexicon terminology: can it be differentiated from pure invasive disease? , 2005, Magnetic resonance imaging.
[64] W H Perman,et al. Dynamic sequential 3D gadolinium-enhanced MRI of the whole breast. , 1996, Magnetic resonance imaging.
[65] B. Lai,et al. Gadolinium-conjugated TiO2-DNA oligonucleotide nanoconjugates show prolonged intracellular retention period and T1-weighted contrast enhancement in magnetic resonance images. , 2008, Nanomedicine : nanotechnology, biology, and medicine.
[66] Raymond C Boston,et al. A modified logistic model to describe gadolinium kinetics in breast tumors. , 2004, Magnetic resonance imaging.
[67] Laura Cortesi,et al. Multicenter comparative multimodality surveillance of women at genetic-familial high risk for breast cancer (HIBCRIT study): interim results. , 2007, Radiology.
[68] S. Heywang-Köbrunner,et al. In situ and minimally invasive breast cancer: morphologic and kinetic features on contrast-enhanced MR imaging , 2000, Magma: Magnetic Resonance Materials in Physics, Biology, and Medicine.
[69] J O Barentsz,et al. Breast tumors: comparative accuracy of MR imaging relative to mammography and US for demonstrating extent. , 1995, Radiology.
[70] M. Kurosumi,et al. Extension of ductal carcinoma in situ: histopathological association with MR imaging and mammography. , 2003, Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine.
[71] S. Holm. A Simple Sequentially Rejective Multiple Test Procedure , 1979 .
[72] L D Buadu,et al. Breast lesions: correlation of contrast medium enhancement patterns on MR images with histopathologic findings and tumor angiogenesis. , 1996, Radiology.
[73] Ying Lu,et al. Kinetic assessment of breast tumors using high spatial resolution signal enhancement ratio (SER) imaging , 2007, Magnetic resonance in medicine.
[74] Women at high risk for breast cancer. , 1998, The American journal of nursing.
[75] Stefan Vogt,et al. MAPS : A set of software tools for analysis and visualization of 3D X-ray fluorescence data sets , 2003 .
[76] J. L. Abraham,et al. Tissue distribution and kinetics of gadolinium and nephrogenic systemic fibrosis. , 2008, European journal of radiology.
[77] G S Karczmar,et al. A new method for imaging perfusion and contrast extraction fraction: Input functions derived from reference tissues , 1998, Journal of magnetic resonance imaging : JMRI.
[78] Peter Aspelin,et al. Dynamic MR Imaging Of The Breast , 2003 .
[79] R. Fimmers,et al. Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[80] L. Liberman,et al. Underestimation of DCIS at MRI-guided vacuum-assisted breast biopsy. , 2007, AJR. American journal of roentgenology.
[81] P S Tofts,et al. Quantitative Analysis of Dynamic Gd‐DTPA Enhancement in Breast Tumors Using a Permeability Model , 1995, Magnetic resonance in medicine.
[82] Nola Hylton,et al. MR imaging for assessment of breast cancer response to neoadjuvant chemotherapy. , 2006, Magnetic resonance imaging clinics of North America.
[83] C K Kuhl,et al. Dynamic image interpretation of MRI of the breast , 2000, Journal of magnetic resonance imaging : JMRI.
[84] Edna Schechtman,et al. Magnetic resonance imaging reveals functional diversity of the vasculature in benign and malignant breast lesions , 2005, Cancer.
[85] S G Orel. MR imaging of the breast. , 2000, Radiologic clinics of North America.
[86] M. Mehta,et al. Gadolinium in human glioblastoma cells for gadolinium neutron capture therapy. , 2001, Cancer research.
[87] C. Gatsonis,et al. Cancer yield of mammography, MR, and US in high-risk women: prospective multi-institution breast cancer screening study. , 2007, Radiology.
[88] S. Heffelfinger,et al. Angiogenic growth factors in preinvasive breast disease. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[89] J L Evelhoch,et al. Key factors in the acquisition of contrast kinetic data for oncology , 1999, Journal of magnetic resonance imaging : JMRI.
[90] L. Liberman,et al. Ductal enhancement on MR imaging of the breast. , 2003, AJR. American journal of roentgenology.
[91] Peter B Barker,et al. Benign and malignant breast lesions: diagnosis with multiparametric MR imaging. , 2003, Radiology.
[92] M. Schnall,et al. MR imaging of ductal carcinoma in situ. , 1997, Radiology.
[93] S E Harms,et al. Evaluation of neoadjuvant chemotherapeutic response of locally advanced breast cancer by magnetic resonance imaging , 1996, Cancer.
[94] H. Lehr,et al. Dynamic MR imaging of breast lesions: correlation with microvessel distribution pattern and histologic characteristics of prognosis. , 2006, Radiology.
[95] Laura Esserman,et al. Contrast‐Enhanced Magnetic Resonance Imaging to Assess Tumor Histopathology and Angiogenesis in Breast Carcinoma , 1999, The breast journal.
[96] Acta R Adiologica. Analysis of kinetic and morphologic diagnostic criteria , 2003 .
[97] Elizabeth A Morris,et al. Nonpalpable mammographically occult invasive breast cancers detected by MRI. , 2006, AJR. American journal of roentgenology.
[98] L. Liberman,et al. Breast lesions detected on MR imaging: features and positive predictive value. , 2002, AJR. American journal of roentgenology.
[99] Xiaobing Fan,et al. New model for analysis of dynamic contrast‐enhanced MRI data distinguishes metastatic from nonmetastatic transplanted rodent prostate tumors , 2004, Magnetic resonance in medicine.
[100] Ying Lu,et al. Invasive breast cancer: predicting disease recurrence by using high-spatial-resolution signal enhancement ratio imaging. , 2008, Radiology.
[101] T. Frenzel,et al. Preclinical investigation to compare different gadolinium-based contrast agents regarding their propensity to release gadolinium in vivo and to trigger nephrogenic systemic fibrosis-like lesions , 2008, European Radiology.
[102] D B Kopans,et al. Benign and malignant breast lesions: differentiation with echo-planar MR imaging. , 1995, Radiology.